Skip to main content
OpenTrials

Clinical trial condition

Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma

Explore clinical trials studying Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma. Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma trial results

Recruiting

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

NCT05475925

Conditions
Aggressive NK Cell Leukemia, Cutaneous PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker), Cytotoxic PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker), +27 more
Locations
  • Dren Investigational Site Birmingham, Alabama, United States
  • Dren Investigational Site Duarte, California, United States
  • Dren Investigational Site Irvine, California, United States
  • Dren Investigational Site Redwood City, California, United States
View all 37 locations
View Trial Details
Recruiting

A Registry for People With T-cell Lymphoma

NCT05978141

Conditions
Adult T-Cell Leukemia/Lymphoma, Aggressive NK-cell Leukemia, Anaplastic Large Cell Lymphoma, ALK-Positive, +54 more
Locations
  • City of Hope Cancer Center (Data collection only) Duarte, California, United States
  • UNIVERSITY OF CALIFORNIA SAN DIEGO (Data collection only) San Diego, California, United States
  • University of California San Francisco (Data collection only) San Francisco, California, United States
  • Stanford University Medical Center (Data collection only) Stanford, California, United States
View all 26 locations
View Trial Details

Related conditions